Clinical Trials in Nashville

Showing 7721-7740 of 15,379 trials

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

NCT00550277

Inhibition of histone deacetylase (HDAC) provides a novel approach for cancer treatment. LBH589, an oral HDAC inhibitor, has been well tolerated in phase I trials and has shown activity against several types of cancer. In this nonrandomized phase II trial, we are investigating the activity of LBH589 in the treatment of patients with refractory clear cell renal carcinoma.

Renal Cell Carcinoma

SCRI Development Innovations, LLC20 participantsStarted Jan 2008

Fort Myers, Florida, United States • Gainesville, Georgia, United States • Baton Rouge, Louisiana, United States +7 more locations

WITHDRAWNNA< 1 mile

Breathing Device for Orthostatic Hypotension (OH)

NCT00962884

The investigators will test whether breathing through an inspiratory resistance device will improve the ability to be upright and decrease blood pressure drops on standing in patients with orthostatic hypotension.

Orthostatic Hypotension

Alfredo GamboaStarted Dec 2010

Nashville, Tennessee, United States

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

Breathing Device for Orthostatic Hypotension (OH)

Find Trials by Condition in Nashville

STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia

Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease

Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis

Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas

Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion

Alphanate in Immune Tolerance Induction Therapy

Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System

Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma

InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study

To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients

Low InTensity Exercise Intervention in PAD

A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer

The Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers

Connected Catheter- Safety and Effectiveness Study

Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection.